In NSCLC, expression of AFAP1-AS1 is significantly increased in tumor tissues, and knockdown of AFAP1-AS1 significantly inhibits the invasive and migration capability of lung cancer cells (Zeng et al., 2016). The gene discussed is AFAP1; the disease is lung cancer.